Disclosures for "Assessing the Co-Chaperone and Synaptic Protein DNAJC5 as a Therapeutic Target in Alzheimer’s Disease")
-
Dr. Rosene has nothing to disclose.
-
Dr. Nykanen has nothing to disclose.
-
Kevin O'Dell has nothing to disclose.
-
Ms. Nunez has nothing to disclose.
-
Dr. Harari has nothing to disclose.
-
John Cirrito has nothing to disclose.
-
Prof. Sands has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for M6P Therapeutics. Prof. Sands has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus. Prof. Sands has stock in JAYA Biosciences. The institution of Prof. Sands has received research support from JAYA Biosciences. Prof. Sands has received intellectual property interests from a discovery or technology relating to health care.
-
Bruno Benitez has nothing to disclose.